Conavi Medical to Showcase FDA-Cleared Hybrid Imaging System at TCT 2026

TORONTO, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing and marketing imaging technologies to guide minimally invasive cardiovascular procedures, today announced its participation in Transcatheter Cardiovascular Therapeutics (TCT) 2026, taking place October 31–November 3, 2026, at the San Diego Convention Center in San Diego, California.

Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.